ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

CLSD Clearside Biomedical Inc

1.35
0.03 (2.27%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Clearside Biomedical Inc CLSD 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.03 2.27% 1.35 07:09:02
개장가 저가 고가 종가 전일 종가
1.34 1.29 1.35 1.31 1.32
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202420:05GLOBEClearside Biomedical to Report First Quarter 2024 Financial..
16/04/202420:05GLOBEClearside Biomedical Appoints Seasoned Biotechnology..
02/04/202420:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
18/03/202420:05GLOBEClearside Biomedical Appoints Victor Chong, M.D., MBA as..
13/03/202405:05GLOBEClearside Biomedical Announces Fourth Quarter and Full Year..
29/02/202421:05GLOBEClearside Biomedical to Report Fourth Quarter and Full Year..
09/02/202407:05EDGAR2Form 8-K - Current report
09/02/202406:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/02/202422:00GLOBEClearside Biomedical Announces Pricing of $15 Million..
02/02/202406:01EDGAR2Form 8-K - Current report
20/01/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202405:04EDGAR2Form 144 - Report of proposed sale of securities
29/12/202306:10EDGAR2Form 8-K - Current report
14/12/202321:05GLOBEClearside Biomedical Reports Significant Progress in ODYSSEY..
14/11/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:10EDGAR2Form 8-K - Current report
14/11/202306:05GLOBEClearside Biomedical Announces Third Quarter 2023 Financial..
08/11/202321:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
08/11/202306:20GLOBEClearside Biomedical’s Versatile Suprachoroidal Injection..
04/11/202301:01EDGAR2Form 8-K - Current report
04/11/202301:00GLOBEBioCryst and Clearside Biomedical Enter Partnership to..
02/11/202320:05GLOBEClearside Biomedical Announces Presentations at the American..
01/11/202320:05GLOBEClearside Biomedical Completes Recruitment in ODYSSEY Phase..
31/10/202320:05GLOBEClearside Biomedical to Report Third Quarter 2023 Financial..
16/10/202320:05GLOBEClearside Biomedical Positive OASIS and Extension Study Data..
04/10/202322:00GLOBEClearside Biomedical Announces Advancement of XIPERE® in..
04/10/202305:35GLOBEClearside Biomedical to Participate in a Panel Discussion at..
30/09/202305:46EDGAR2Form 8-K - Current report
26/09/202305:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/09/202305:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/09/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/09/202320:05GLOBEClearside Biomedical to Participate in Panel Discussion at..
14/09/202307:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202305:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/08/202305:11EDGAR2Form 8-K - Current report
15/08/202305:05GLOBEClearside Biomedical Announces Second Quarter 2023 Financial..
03/08/202305:30GLOBEClearside Biomedical to Participate in Upcoming Investor..
01/08/202320:05GLOBEClearside Biomedical to Report Second Quarter 2023 Financial..
31/07/202320:05GLOBEClearside Biomedical Highlights Excellent Safety Profile of..
20/07/202320:05GLOBEClearside Biomedical’s Suprachoroidal Injection Platform to..
17/07/202320:05GLOBEClearside Biomedical Announces Enrollment of Multiple..
12/07/202305:05GLOBEClearside Biomedical CEO George Lasezkay to Present at the..
10/07/202320:05GLOBEClearside Biomedical Asia-Pacific Partner Arctic Vision..
01/06/202320:05GLOBEClearside Biomedical Opens Enrollment in ODYSSEY Phase 2b..
11/05/202320:05GLOBEClearside Biomedical Announces First Quarter 2023 Financial..
10/05/202305:30GLOBEClearside Biomedical to Participate in a Fireside Chat at..

최근 히스토리

Delayed Upgrade Clock